Optimising pharmaceutical care for people with dementia in acute care settings

优化急性护理环境中痴呆症患者的药学护理

• 批准号: nhmrc : 1136849
• 负责人: Dr Danijela Gnjidic
• 金额: $ 48.6万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Targeted Calls
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/optimising-pharmaceutical-care-care-settings/1318504
• 关键词: Optimising; pharmaceutical; care; people; dementia

Delivering appropriate acute care services for people with dementia is a major healthcare challenge in Australia. People with dementia do not receive appropriate care in hospitals and are more likely to experience worse clinical outcomes compared to people without dementia. This proposal will establish the first large-scale multi-centre cohort of inpatients with dementia, to systematically investigate the impact of hospitalisation on prescribing, clinical and patient-centred outcomes.

在澳大利亚，为痴呆症患者提供适当的急性护理服务是一项重大的医疗挑战。痴呆症患者在医院得不到适当的护理，与非痴呆症患者相比，更有可能经历更糟糕的临床结果。这项提议将建立第一个大规模的多中心痴呆症住院患者队列，系统地调查住院对处方、临床和以患者为中心的结果的影响。